Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.7 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |